EDP Sciences logo
Submit your paper
Search
Menu
All issues Volume 57 / No 4 (December 2025) J Extra Corpor Technol, 57 4 (2025) 235-242 References
Open Access
Issue
J Extra Corpor Technol
Volume 57, Number 4, December 2025
Page(s) 235 - 242
DOI https://doi.org/10.1051/ject/2025031
Published online 17 December 2025
  1. Malcolm WF. Beyond the NICU: comprehensive care of the high-risk infant. New York: McGraw-Hill Education; 2015: 968 p. [Google Scholar]
  2. Fawaz R, Baumann U, Ekong U, Fischler B, Hadzic N, Mack CL, et al. Guideline for the evaluation of cholestatic jaundice in infants: joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr. 2017;64(1):154–168. [Google Scholar]
  3. Alexander E, O’Sullivan D, Aganga D, Hassan S, Ibrahim SH, Absah I. Clinical implications for children developing direct hyperbilirubinemia on extracorporeal membrane oxygenation. J Pediatr Gastroenterol Nutr. 2022;74(3):333–337. [Google Scholar]
  4. Abbasi S, Stewart DL, Radmacher P, Adamkin D. Natural course of cholestasis in neonates on extracorporeal membrane oxygenation (ECMO): 10-year experience at a single institution. ASAIO J 2008;54(4):436–438. [Google Scholar]
  5. Walsh-Sukys MC. The natural history of direct hyperbilirubinemia associated with extracorporeal membrane oxygenation. Arch Pediatr Adolesc Med. 1992;146(10):1176. [Google Scholar]
  6. O’Brien C, Monteagudo J, Schad C, Cheung E, Middlesworth W. Centrifugal pumps and hemolysis in pediatric extracorporeal membrane oxygenation (ECMO) patients: an analysis of Extracorporeal Life Support Organization (ELSO) registry data. J Pediatr Surg. 2017;52(6):975–978. [Google Scholar]
  7. Chu JH, Sarathy S, Ramesh S, Rudolph K, Raghavan ML, Badheka A. Risk factors for hemolysis with centrifugal pumps in pediatric extracorporeal membrane oxygenation: is pump replacement an answer? Perfusion. 2023;38(4):771–780. [Google Scholar]
  8. O’Halloran CP, Thiagarajan RR, Yarlagadda VV, Barbaro RP, Nasr VG, Rycus P, et al. Outcomes of infants supported with extracorporeal membrane oxygenation using centrifugal versus roller pumps: an analysis from the Extracorporeal Life Support Organization registry. Pediatr Crit Care Med. 2019;20(12):1177–1184. [Google Scholar]
  9. Maul TM, Aspenleiter M, Palmer D, Sharma MS, Viegas ML, Wearden PD. Impact of circuit size on coagulation and hemolysis complications in pediatric extracorporeal membrane oxygenation. ASAIO J. 2020;66(9):1048–1053. [Google Scholar]
  10. Lemloh L, Bo B, Ploeger H, Dolscheid-Pommerich R, Mueller A, Kipfmueller F. Hemolysis during venovenous extracorporeal membrane oxygenation in neonates with congenital diaphragmatic hernia: a prospective observational study. J Pediatr. 2023;263:113713. [Google Scholar]
  11. Masha L, Peerbhai S, Boone David, Shobayo F, Ghotra A, Akkanti B, et al. Yellow means caution: correlations between liver injury and mortality with the use of VA-ECMO. ASAIO J. 2019;65(8):812–818. [Google Scholar]
  12. Huang R, Shao M, Zhang C, Fang M, Jin M, Han X, et al. Serum total bilirubin with hospital survival in adults during extracorporeal membrane oxygenation. Front Med. 2022;9:914557. [Google Scholar]
  13. Dobrilovic N, March R, Yin K, Lateef O, Alimohamed M, Bak E, et al. Liver dysfunction associated with in-hospital mortality in adult extracorporeal membrane oxygenation support. Crit Care Explor. 2021;3(7):e0484. [Google Scholar]
  14. Wild KT, Rintoul N, Kattan J, Gray B. Extracorporeal life support organization (ELSO): guidelines for neonatal respiratory failure. ASAIO J. 2020;66(5):463–470. [CrossRef] [PubMed] [Google Scholar]
  15. Maul TM, Herrera G. Coagulation and hemolysis complications in neonatal ECLS: role of devices. Semin Fetal Neonatal Med. 2022;27(6):101405. [Google Scholar]
  16. Melchior R, Sutton S, Harris W, Dalton H. Evolution of membrane oxygenator technology for utilization during pediatric cardiopulmonary bypass. Pediatr Health Med Ther. 2016;7:45–56. [Google Scholar]
  17. Williams DC, Turi JL, Hornik CP, Bonadonna DK, Williford WL, Walczak RJ, et al. Circuit oxygenator contributes to extracorporeal membrane oxygenation-induced hemolysis. ASAIO J. 2015;61(2):190–195. [CrossRef] [PubMed] [Google Scholar]
  18. Davalos D, Akassoglou K. Fibrinogen as a key regulator of inflammation in disease. Semin Immunopathol. 2012;34(1):43–62. [Google Scholar]
  19. Kawahito S, Maeda T, Motomura T, Ishitoya H. Hemolytic characteristics of oxygenators during clinical extracorporeal membrane oxygenation. ASAIO J. 2002;48(6):636–639. [Google Scholar]
  20. Venema LH, Sharma AS, Simons AP, Bekers O, Weerwind PW. Contemporary oxygenator design relative to hemolysis. J Extracorpor Technol. 2014;46(3):212–216. [Google Scholar]
  21. Sun W, Wang S, Chen Z, Zhang J, Li T, Arias K, et al. Impact of high mechanical shear stress and oxygenator membrane surface on blood damage relevant to thrombosis and bleeding in a pediatric ECMO circuit. Artif Organs. 2020;44(7):717–726. [CrossRef] [PubMed] [Google Scholar]
  22. De Somer D, Foubert L, Vanackere M, Dujardin D, Delanghe J, Van Nooten G, Impact of oxygenator design on hemolysis, shear stress, and white blood cell and platelet counts. J Cardiothorac Vasc Anesth. 1996;10(7):884–889. [Google Scholar]
  23. Cashen K, Meert K, Dalton H. Anticoagulation in neonatal ECMO: an enigma despite a lot of effort! Front Pediatr. 2019;7:366. [Google Scholar]
  24. Cortesi V, Raffaeli G, Amelio GS, Amodeo I, Gulden S, Manzoni F, et al. Hemostasis in neonatal ECMO. Front Pediatr. 2022;10:988681. [Google Scholar]
  25. Joyce PR, Hodgson CL, Bellomo R, Gregory SD, Raman J, Stephens AF, et al. Smaller return cannula in venoarterial extracorporeal membrane oxygenation does not increase hemolysis: a single-center, cohort study. ASAIO J. 2023;69(11):1004–1008. [Google Scholar]
  26. Appelt H, Philipp A, Mueller T, Foltan M, Lubnow M, Lunz D, et al. Factors associated with hemolysis during extracorporeal membrane oxygenation (ECMO) – Comparison of VA- versus VV ECMO. PLoS One. 2020;15(1):e0227793. [CrossRef] [PubMed] [Google Scholar]
  27. Okochi S, Cheung EW, Barton S, Zenilman A, Shakoor A, Street C, et al. An analysis of risk factors for hemolysis in children on extracorporeal membrane oxygenation. Pediatr Crit Care Med. 2018;19(11):1059–1066. [CrossRef] [PubMed] [Google Scholar]
  28. Betrus C, Remenapp R, Charpie J, Kudelka T, Brophy P, Smoyer WE, et al. Enhanced hemolysis in pediatric patients requiring extracorporeal membrane oxygenation and continuous renal replacement therapy. Ann Thorac Cardiovasc Surg. 2007;13(6):378–383. [PubMed] [Google Scholar]
  29. Okochi S, Cheung EW, Barton S, Zenilman A, Shakoor A, Street C, et al. An analysis of risk factors for hemolysis in children on extracorporeal membrane oxygenation. Pediatr Crit Care Med. 2018;19(11):1059–1066. [CrossRef] [PubMed] [Google Scholar]
  30. Lou S, MacLaren G, Best D, Delzoppo C, Butt W. Hemolysis in pediatric patients receiving centrifugal-pump extracorporeal membrane oxygenation: prevalence, risk factors, and outcomes. Crit Care Med. 2014;42(5):1213–1220. [CrossRef] [PubMed] [Google Scholar]
  31. Omar HR, Mirsaeidi M, Socias S, Sprenker C, Caldeira C, Camporesi EM, et al. Plasma free hemoglobin is an independent predictor of mortality among patients on extracorporeal membrane oxygenation support. PLoS One. 2015;10(4):e0124034. [CrossRef] [PubMed] [Google Scholar]
  32. Borasino S, Kalra Y, Elam AR, Carlisle O’Meara L, Timpa JG, Goldberg KG, et al. Impact of hemolysis on acute kidney injury and mortality in children supported with cardiac extracorporeal membrane oxygenation. J Extra Corpor Technol. 2018;50(4):217–224. [PubMed] [Google Scholar]
  33. Chan C, Ki K, Zhang M, Asnicar C, Cho HJ, Ainola C, et al. Extracorporeal membrane oxygenation-induced hemolysis: an in vitro study to appraise causative factors. Membranes. 2021;11(5):313. [Google Scholar]
  34. Ozment C, Alexander PMA, Chandler W, Emani S, Hyslop R, Monagle P, et al. Anticoagulation monitoring and targets: the pediatric extracorporeal membrane oxygenation anticoagulation collaborativE consensus conference. Pediatr Crit Care Med. 2024;25(7):e14–e24. [Google Scholar]
  35. Muszynski JA, Bembea MM, Gehred A, Lyman E, Cashen K, Cheifetz IM, et al. Priorities for clinical research in pediatric extracorporeal membrane oxygenation anticoagulation from the pediatric extracorporeal membrane oxygenation anticoagulation collaborativE consensus conference. Pediatr Crit Care Med. 2024;25(7):e78–e89. [Google Scholar]
  36. Ezetendu C, Jarden A, Hamzah M, Stewart R. Bivalirudin anticoagulation for an infant with hyperbilirubinemia and elevated plasma-free hemoglobin on ECMO. J Extra Corpor Technol. 2019;51(1):26–28. [Google Scholar]
  37. Ryerson LM, Balutis KR, Granoski DA, Nelson LAR, Massicotte MP, Lequier LL, et al. Prospective exploratory experience with bivalirudin anticoagulation in pediatric extracorporeal membrane oxygenation. Pediatr Crit Care Med. 2020;21(11):975–985. [Google Scholar]
  38. McMichael A, Weller J, Li X, Hatton L, Zia A, Raman L. Prospective randomized pilot study comparing bivalirudin versus heparin in neonatal and pediatric extracorporeal membrane oxygenation. Pediatr Crit Care Med. 2025;26(1):e86–e94. [Google Scholar]
  39. Machado DS, Garvan C, Philip J, Harrington D, Spiess B, Kelly B, et al. Bivalirudin may reduce the need for red blood cell transfusion in pediatric cardiac patients on extracorporeal membrane oxygenation. ASAIO J. 2021;67(6):688–696. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.